Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Veracyte, Inc. (VCYT)
USD57.47
-0.01 (-0.01%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
6000 Shoreline Court 94080
South San Francisco, CA, US
South San Francisco, CA, US
CEO
Marc Stapley
Website
veracyte.com
IPO
2013-10-29
CIK 1384101 ISIN US92337F1075
Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
News Sentiment (7d)
3 articles
- All You Need to Know About Veracyte (VCYT) Rating Upgrade to Strong Buy Zacks Investment Research
- Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026 Business Wire
- A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction. The Motley Fool
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD57.47
-0.01 (-0.01%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.98
Float Shares
79.02M
Free Float %
99.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.35% | -3.91% | +27.24% | +12.55% | -6.48% | -6.03% | +28.61% | +68.20% | +8.50% | +652.09% | +198.57% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (20 ratings, all time)
Buy
Price Targets & DCF
Current price
57.47
Low
37.00
-35.6%
Consensus
45.25
-21.3%
Median
46.00
-20.0%
High
52.00
-9.5%
DCF (Unlevered)
40.82
-29.0%
DCF (Levered)
43.15
-24.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
83% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 9 | 0 |
| Hold | 1 | -1 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
47.00
-18.2%
|
| Last Quarter | 3 |
43.67
-24.0%
|
| Last Year | 9 |
43.11
-25.0%
|
| All Time | 13 |
39.00
-32.1%
|
Quality scores
Altman Z-Score
21.66
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+16.0% ★ Q1'26: +21.5% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+164.5% ★ Q1'26: +297.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%+14.7% ★ Q1'26: +23.2% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%+13.2% ★ Q1'26: +17.1% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%+7.1% ★ Q1'26: +9.7% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+3.1% Q1'26: +1.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×0.44× ★ Q1'26: 0.34× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 5 EPS Ana. |
Dec 2027 9 Rev. Ana. 6 EPS Ana. |
Dec 2028 8 Rev. Ana. 2 EPS Ana. |
Dec 2029 7 Rev. Ana. 1 EPS Ana. |
Dec 2030 7 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
49.50M
est: 49.65M (-0.3%)
|
65.09M
est: 64.32M (+1.2%)
|
71.95M
est: 71.28M (+0.9%)
|
92.01M
est: 90.69M (+1.5%)
|
120.37M
est: 120.22M (+0.1%)
|
117.48M
est: 115.33M (+1.9%)
|
219.51M
est: 214.82M (+2.2%)
|
296.54M
est: 291.31M (+1.8%)
|
361.05M
est: 399.58M (-9.6%)
|
445.76M
est: 443.91M (+0.4%)
|
517.15M
est: 511.67M (+1.1%)
|
584.08M
581.35M – 585.99M
+14.1% YoY
|
653.34M
643.42M – 658.37M
+11.9% YoY
|
718.88M
717.84M – 719.91M
+10.0% YoY
|
804.57M
790.35M – 818.18M
+11.9% YoY
|
878.97M
863.44M – 893.84M
+9.2% YoY
|
| EBITDA |
-32.53M
est: -5.48M (-493.6%)
|
-25.09M
est: -7.10M (-253.5%)
|
-23.76M
est: -23.85M (+0.4%)
|
-17.12M
est: -19.65M (+12.9%)
|
-7.81M
est: -6.78M (-15.1%)
|
-26.74M
est: -19.00M (-40.7%)
|
-60.18M
est: -156.96M (+61.7%)
|
-6.98M
est: -40.33M (+82.7%)
|
-49.41M
est: 199.76M (-124.7%)
|
49.21M
est: 221.93M (-77.8%)
|
89.62M
est: 255.80M (-65.0%)
|
292.00M
290.64M – 292.95M
+14.1% YoY
|
326.62M
321.67M – 329.14M
+11.9% YoY
|
359.39M
358.87M – 359.90M
+10.0% YoY
|
402.23M
395.12M – 409.04M
+11.9% YoY
|
439.42M
431.66M – 446.86M
+9.2% YoY
|
| EBIT |
-33.33M
est: -9.36M (-256.0%)
|
-28.65M
est: -12.13M (-136.3%)
|
-27.60M
est: -26.98M (-2.3%)
|
-21.04M
est: -25.97M (+19.0%)
|
-11.92M
est: -15.79M (+24.5%)
|
-34.68M
est: -33.53M (-3.4%)
|
-81.41M
est: -183.99M (+55.8%)
|
-36.23M
est: -62.81M (+42.3%)
|
-76.60M
est: 198.29M (-138.6%)
|
25.75M
est: 220.29M (-88.3%)
|
68.20M
est: 253.92M (-73.1%)
|
289.84M
288.49M – 290.79M
+14.1% YoY
|
324.22M
319.30M – 326.71M
+11.9% YoY
|
356.74M
356.23M – 357.25M
+10.0% YoY
|
399.26M
392.21M – 406.02M
+11.9% YoY
|
436.18M
428.48M – 443.56M
+9.2% YoY
|
| Net Income |
-33.70M
est: -101.96M (+66.9%)
|
-31.36M
est: -95.75M (+67.3%)
|
-31.00M
est: -31.13M (+0.4%)
|
-23.00M
est: -26.91M (+14.5%)
|
-12.60M
est: -12.62M (+0.2%)
|
-34.91M
est: -27.31M (-27.8%)
|
-75.56M
est: -170.25M (+55.6%)
|
-36.56M
est: -29.06M (-25.8%)
|
-74.40M
est: -58.57M (-27.0%)
|
24.14M
est: 28.95M (-16.6%)
|
66.35M
est: 134.41M (-50.6%)
|
137.76M
121.02M – 154.50M
+2.5% YoY
|
145.99M
127.64M – 164.34M
+6.0% YoY
|
159.73M
153.95M – 165.50M
+9.4% YoY
|
174.84M
170.83M – 178.69M
+9.5% YoY
|
188.54M
184.21M – 192.69M
+7.8% YoY
|
| SGA |
47.88M
est: 31.22M (+53.4%)
|
52.04M
est: 40.44M (+28.7%)
|
55.35M
est: 63.88M (-13.4%)
|
65.28M
est: 77.03M (-15.3%)
|
82.72M
est: 99.91M (-17.2%)
|
89.12M
est: 95.39M (-6.6%)
|
181.19M
est: 135.06M (+34.2%)
|
174.08M
est: 206.90M (-15.9%)
|
184.23M
est: 223.19M (-17.5%)
|
206.04M
est: 247.96M (-16.9%)
|
210.95M
est: 285.81M (-26.2%)
|
326.25M
324.73M – 327.32M
+14.1% YoY
|
364.94M
359.40M – 367.75M
+11.9% YoY
|
401.54M
400.97M – 402.12M
+10.0% YoY
|
449.41M
441.47M – 457.02M
+11.9% YoY
|
490.97M
482.30M – 499.28M
+9.2% YoY
|
| EPS |
-1.30
est: -1.30 (+0.3%)
|
-1.09
est: -1.23 (+11.0%)
|
-0.91
est: -0.87 (-5.1%)
|
-0.62
est: -0.70 (+11.7%)
|
-0.27
est: -0.20 (-35.0%)
|
-0.66
est: -0.61 (-7.5%)
|
-1.11
est: -1.14 (+2.3%)
|
-0.51
est: -0.61 (+16.1%)
|
-1.02
est: -0.73 (-40.2%)
|
0.32
est: 0.36 (-11.1%)
|
0.84
est: 1.66 (-49.5%)
|
1.78
1.50 – 1.92
+7.0% YoY
|
1.87
1.58 – 2.04
+5.3% YoY
|
1.98
1.91 – 2.05
+5.8% YoY
|
2.17
2.12 – 2.22
+9.5% YoY
|
2.34
2.29 – 2.39
+7.8% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-06 | UBS | Buy | Buy | Maintain |
| 2026-04-20 | Canaccord Genuity | Hold | Hold | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
164.51M
OE per share TTM
2.04
Owner's Yield
5.23%
Maintenance CapEx ratio
0.30%
Maint CapEx / Avg PPE
12.4%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
50
Total invested
39.64M
Insider transactions (90d)
0
Beneficial owners (>5%)
28
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group - 23-1945930 | 6.60M | 9.28% | — | 56.3K | 6.48M | 118.2K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 2 | (1) BlackRock, Inc. | 6.27M | 8.80% | 6.04M | — | 6.27M | — | HC | Delaware | 2022-02-03 | ↗ |
| 3 | Wellington Group Holdings LLP | 5.08M | 7.15% | — | 4.47M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 4 | Wellington Investment Advisors Holdings LLP | 5.08M | 7.15% | — | 4.47M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 5 | Wellington Management Group LLP | 5.08M | 7.15% | — | 4.47M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 6 | Artisan Investments GP LLC | 5.02M | 6.50% | — | 3.99M | — | 5.02M | HC | Delaware | 2024-11-12 | ↗ |
| 7 | Artisan Partners Asset Management Inc. | 5.02M | 6.50% | — | 3.99M | — | 5.02M | HC | Delaware | 2024-11-12 | ↗ |
| 8 | Artisan Partners Holdings LP | 5.02M | 6.50% | — | 3.99M | — | 5.02M | HC | Delaware | 2024-11-12 | ↗ |
| 9 | Artisan Partners Limited Partnership | 5.02M | 6.50% | — | 3.99M | — | 5.02M | IA | Delaware | 2024-11-12 | ↗ |
| 10 | Wellington Management Company LLP | 4.81M | 6.78% | — | 4.44M | — | — | IA | Delaware | 2022-02-04 | ↗ |
| 11 | STATE STREET CORPORATION | 4.16M | 5.80% | — | 4.01M | — | 4.16M | HC | BOSTON, MASSACHUSETTS | 2023-02-06 | ↗ |
| 12 | 98-0557567 | 4.11M | 5.80% | 3.87M | — | 4.11M | — | IA, HC | Bermuda | 2022-02-10 | ↗ |
| 13 | Gilder, Gagnon, Howe & Co. LLC | 3.77M | 7.72% | — | — | — | 3.77M | BD | New York | 2020-02-14 | ↗ |
| 14 | William Blair Investment Management, LLC | 3.57M | 7.30% | 3.24M | — | 3.57M | — | IA | Delaware | 2020-02-10 | ↗ |
| 15 | S | 3.51M | 10.70% | 3.51M | — | 3.51M | — | IA | NUMBER OF | 2017-02-13 | ↗ |
| 16 | Nikko Asset Management Americas, Inc. | 3.12M | 4.39% | — | 2.67M | — | 3.12M | IA | USA | 2022-02-14 | ↗ |
| 17 | Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”) | 3.12M | 4.39% | — | 3.12M | — | 3.12M | FI, HC | Japan | 2022-02-04 | ↗ |
| 18 | Nikko Asset Management Co., Ltd. (“NAM”) | 3.05M | 6.25% | — | 3.05M | — | — | FI, IA, HC | Japan | 2020-02-12 | ↗ |
| 19 | Broadfin Capital, LLC | 1.92M | 5.83% | — | 1.92M | — | 1.92M | IA, OO | Cayman Islands | 2016-11-04 | ↗ |
| 20 | Broadfin Healthcare Master Fund, Ltd. | 1.92M | 5.83% | — | 1.92M | — | 1.92M | CO | Cayman Islands | 2016-11-04 | ↗ |
| 21 | Kevin Kotler | 1.92M | 5.83% | — | 1.92M | — | 1.92M | HC, IN | Cayman Islands | 2016-11-04 | ↗ |
| 22 | 94-3366999 | 1.70M | 4.20% | — | 1.70M | — | — | IA | Wyoming, USA | 2019-02-14 | ↗ |
| 23 | J. Carlo Cannell | 1.70M | 4.20% | — | 1.70M | — | — | HC | USA | 2019-02-14 | ↗ |
| 24 | 2. | 1.44M | 5.24% | — | 1.44M | — | 1.44M | IA | UNITED STATES | 2015-06-01 | ↗ |
| 25 | CAPITAL PARTNERS LLC 45-2817402 | 442.5K | 1.10% | 442.5K | — | 442.5K | — | IA | OF DELAWARE | 2019-02-14 | ↗ |
| 26 | Bonderman | — | 0.00% | — | — | — | — | IN | Delaware | 2020-02-13 | ↗ |
| 27 | G. Coulter | — | 0.00% | — | — | — | — | IN | Delaware | 2020-02-13 | ↗ |
| 28 | Group Holdings (SBS) Advisors, Inc. | — | 0.00% | — | — | — | — | CO | Delaware | 2020-02-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
50
-283 vs prev Q
New positions
5
Closed positions
285
Increased
24
Reduced
17
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 13.13M +76.7K (+0.6%) | 552.72M +104.6M (+23.4%) | 16.68% -0.012 pp | 0.01% +0.002 pp | USD34.09 +23.5% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 8.50M -77.0 (0.0%) | 358.02M +66.1M (+22.6%) | 10.80% -0.071 pp | 0.01% +0.001 pp | USD34.98 +20.4% | 49 qtrs — |
| 3 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 6.26M -1.1M (-15.0%) | 263.67M +10.6M (+4.2%) | 7.96% -1.468 pp | 0.39% +0.036 pp | USD34.19 +23.1% | 26 qtrs — |
| 4 | FMR LLC | 5.74M -1.1M (-15.6%) | 241.58M +8.3M (+3.6%) | 7.29% -1.400 pp | 0.01% +0.000 pp | USD31.77 +32.5% | 25 qtrs — |
| 5 | STATE STREET CORP | 4.36M +161.2K (+3.8%) | 183.59M +39.4M (+27.3%) | 5.54% +0.170 pp | 0.01% +0.001 pp | USD27.75 +51.7% | 49 qtrs — |
| 6 | ARK INVESTMENT MANAGEMENT LLC | 3.89M -578.2K (-12.9%) | 163.67M +10.4M (+6.8%) | 4.94% -0.772 pp | 1.09% +0.174 pp | USD29.98 +40.4% | 37 qtrs — |
| 7 | DIMENSIONAL FUND ADVISORS LP | 2.80M -317.7K (-10.2%) | 117.90M +10.9M (+10.1%) | 3.56% -0.430 pp | 0.02% +0.002 pp | USD22.64 +86.0% | 22 qtrs — |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 2.04M -1.3M (-39.6%) | 85.73M -30.1M (-26.0%) | 2.59% -1.726 pp | 0.02% -0.005 pp | USD32.63 +29.0% | 26 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.90M +9.4K (+0.5%) | 80.04M +15.1M (+23.2%) | 2.41% -0.004 pp | 0.00% +0.001 pp | USD27.29 +54.3% | 48 qtrs — |
| 10 | ARROWMARK COLORADO HOLDINGS LLC | 1.56M -984.3K (-38.7%) | 65.74M -21.7M (-24.8%) | 1.98% -1.272 pp | 1.45% -0.177 pp | USD31.36 +34.2% | 24 qtrs — |
| 11 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.38M +1.4M (+100.0%) | 58.16M +58.2M (+100.0%) | 1.75% +1.755 pp | 0.20% +0.197 pp | USD42.10 +0.0% | 1 qtrs NEW |
| 12 | FIRST TRUST ADVISORS LP | 1.28M -41.5K (-3.1%) | 54.04M +8.5M (+18.8%) | 1.63% -0.064 pp | 0.04% +0.005 pp | USD31.56 +33.4% | 25 qtrs — |
| 13 | BANK OF AMERICA CORP /DE/ | 1.26M -38.7K (-3.0%) | 53.17M +8.5M (+19.0%) | 1.60% -0.060 pp | 0.00% +0.001 pp | USD26.25 +60.4% | 46 qtrs — |
| 14 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 1.26M -224.2K (-15.1%) | 52.96M +2.1M (+4.1%) | 1.60% -0.297 pp | 0.61% +0.119 pp | USD28.03 +50.2% | 30 qtrs — |
| 15 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 1.26M -224.2K (-15.1%) | 52.96M +2.1M (+4.1%) | 1.60% -0.297 pp | 0.03% +0.002 pp | USD26.95 +56.2% | 28 qtrs — |
| 16 | GOLDMAN SACHS GROUP INC | 1.19M -145.8K (-10.9%) | 50.28M +4.3M (+9.3%) | 1.52% -0.196 pp | 0.01% +0.001 pp | USD26.58 +58.4% | 44 qtrs — |
| 17 | MORGAN STANLEY | 1.18M +283.1K (+31.5%) | 49.81M +18.9M (+61.2%) | 1.50% +0.352 pp | 0.00% +0.001 pp | USD32.74 +28.6% | 49 qtrs — |
| 18 | GW&K INVESTMENT MANAGEMENT, LLC | 1.14M -143.4K (-11.2%) | 48.00M +3.9M (+8.9%) | 1.45% -0.193 pp | 0.42% +0.025 pp | USD26.57 +58.4% | 25 qtrs — |
| 19 | NORTHERN TRUST CORP | 992.2K -82.2K (-7.6%) | 41.77M +4.9M (+13.3%) | 1.26% -0.113 pp | 0.01% +0.001 pp | USD25.34 +66.1% | 49 qtrs — |
| 20 | IRON TRIANGLE PARTNERS LP | 980.4K +495.4K (+102.1%) | 41.27M +24.6M (+147.9%) | 1.25% +0.625 pp | 4.72% +2.351 pp | USD38.26 +10.0% | 2 qtrs — |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 910.8K +3.1K (+0.3%) | 38.35M +7.2M (+23.0%) | 1.16% -0.004 pp | 0.01% +0.001 pp | USD27.34 +54.0% | 43 qtrs — |
| 22 | FISHER ASSET MANAGEMENT, LLC | 795.7K +62.7K (+8.6%) | 33.50M +8.3M (+33.1%) | 1.01% +0.074 pp | 0.01% +0.002 pp | USD34.61 +21.6% | 20 qtrs — |
| 23 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 790.4K +112.5K (+16.6%) | 33.28M +10.0M (+43.0%) | 1.00% +0.137 pp | 0.09% +0.033 pp | USD35.44 +18.8% | 2 qtrs — |
| 24 | OBERWEIS ASSET MANAGEMENT INC/ | 726.7K +5.1K (+0.7%) | 30.60M +5.8M (+23.5%) | 0.92% +0.000 pp | 1.12% +0.170 pp | USD25.93 +62.4% | 13 qtrs — |
| 25 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 726.0K +— (+0.0%) | 30.56M +5.6M (+22.6%) | 0.92% -0.006 pp | 0.39% +0.010 pp | USD28.05 +50.1% | 3 qtrs — |
| 26 | LEGAL & GENERAL GROUP PLC | 690.8K -94.7K (-12.1%) | 29.08M +2.1M (+7.8%) | 0.88% -0.127 pp | 0.01% +0.000 pp | USD29.26 +43.9% | 37 qtrs — |
| 27 | CHAMPLAIN INVESTMENT PARTNERS, LLC | 688.8K -478.3K (-41.0%) | 29.00M -11.1M (-27.6%) | 0.87% -0.617 pp | 0.29% -0.009 pp | USD34.33 +22.6% | 2 qtrs — |
| 28 | BAMCO INC /NY/ | 645.6K +— (+0.0%) | 27.18M +5.0M (+22.6%) | 0.82% -0.005 pp | 0.07% +0.015 pp | USD29.84 +41.1% | 27 qtrs — |
| 29 | FRED ALGER MANAGEMENT, LLC | 633.9K -133.6K (-17.4%) | 26.69M +339.4K (+1.3%) | 0.81% -0.176 pp | 0.10% +0.002 pp | USD34.33 +22.6% | 2 qtrs — |
| 30 | DRIEHAUS CAPITAL MANAGEMENT LLC | 631.7K +631.7K (+100.0%) | 26.59M +26.6M (+100.0%) | 0.80% +0.802 pp | 0.18% +0.181 pp | USD42.10 +0.0% | 1 qtrs NEW |
| 31 | ALYESKA INVESTMENT GROUP, L.P. | 601.6K +293.5K (+95.3%) | 25.33M +14.8M (+139.5%) | 0.76% +0.370 pp | 0.07% +0.040 pp | USD38.12 +10.4% | 2 qtrs — |
| 32 | SEGALL BRYANT & HAMILL, LLC | 596.3K +62.9K (+11.8%) | 25.10M +6.8M (+37.1%) | 0.76% +0.075 pp | 0.34% +0.096 pp | USD33.09 +27.2% | 20 qtrs — |
| 33 | NEW YORK STATE COMMON RETIREMENT FUND | 586.2K -78.5K (-11.8%) | 24.68M +1.9M (+8.2%) | 0.74% -0.105 pp | 0.03% +0.003 pp | USD29.16 +44.4% | 43 qtrs — |
| 34 | NUVEEN, LLC | 582.3K -139.3K (-19.3%) | 24.51M -257.0K (-1.0%) | 0.74% -0.183 pp | 0.01% 0.000 pp | USD29.65 +42.0% | 4 qtrs — |
| 35 | EVENTIDE ASSET MANAGEMENT, LLC | 570.7K -114.1K (-16.7%) | 24.03M +516.4K (+2.2%) | 0.73% -0.151 pp | 0.38% -0.011 pp | USD16.59 +153.8% | 47 qtrs — |
| 36 | JPMORGAN CHASE & CO | 520.1K +1.3K (+0.2%) | 21.90M +4.1M (+22.9%) | 0.66% -0.003 pp | 0.00% +0.000 pp | USD29.35 +43.4% | 38 qtrs — |
| 37 | AEGON ASSET MANAGEMENT UK PLC | 489.4K +79.8K (+19.5%) | 20.60M +6.5M (+46.5%) | 0.62% +0.098 pp | 0.25% +0.079 pp | USD29.30 +43.7% | 9 qtrs — |
| 38 | PRINCIPAL FINANCIAL GROUP INC | 465.4K +29.6K (+6.8%) | 19.59M +4.6M (+31.0%) | 0.59% +0.034 pp | 0.01% +0.003 pp | USD33.88 +24.3% | 27 qtrs — |
| 39 | BANK OF NEW YORK MELLON CORP | 426.5K -22.8K (-5.1%) | 17.96M +2.5M (+16.4%) | 0.54% -0.033 pp | 0.00% +0.000 pp | USD29.97 +40.5% | 48 qtrs — |
| 40 | POINT72 ASSET MANAGEMENT, L.P. | 426.2K +426.2K (+100.0%) | 17.94M +17.9M (+100.0%) | 0.54% +0.541 pp | 0.02% +0.020 pp | USD42.10 +0.0% | 1 qtrs NEW |
| 41 | INVESCO LTD. | 390.8K -88.8K (-18.5%) | 16.45M -13.3K (-0.1%) | 0.50% -0.117 pp | 0.00% 0.000 pp | USD29.45 +43.0% | 35 qtrs — |
| 42 | SEI INVESTMENTS CO | 385.8K +10.9K (+2.9%) | 16.24M +3.4M (+26.2%) | 0.49% +0.011 pp | 0.02% +0.002 pp | USD32.31 +30.3% | 30 qtrs — |
| 43 | RAYMOND JAMES FINANCIAL INC | 384.3K +187.3K (+95.1%) | 16.24M +9.5M (+140.2%) | 0.49% +0.236 pp | 0.01% +0.003 pp | USD36.70 +14.7% | 5 qtrs — |
| 44 | SILVERARC CAPITAL MANAGEMENT, LLC | 357.6K +121.8K (+51.6%) | 15.05M +7.0M (+86.0%) | 0.45% +0.153 pp | 2.09% +0.999 pp | USD34.56 +21.8% | 20 qtrs — |
| 45 | JUPITER ASSET MANAGEMENT LTD | 355.6K -39.4K (-10.0%) | 14.97M +1.4M (+10.4%) | 0.45% -0.053 pp | 0.12% +0.003 pp | USD34.33 +22.6% | 2 qtrs — |
| 46 | BNP PARIBAS ARBITRAGE, SNC | 352.6K +281.1K (+392.9%) | 14.85M +12.4M (+504.4%) | 0.45% +0.356 pp | 0.01% +0.005 pp | USD40.17 +4.8% | 46 qtrs — |
| 47 | GRANITE INVESTMENT PARTNERS, LLC | 351.0K -125.9K (-26.4%) | 14.78M -1.6M (-9.7%) | 0.45% -0.164 pp | 0.88% -0.054 pp | USD22.89 +83.9% | 24 qtrs — |
| 48 | ROYAL BANK OF CANADA | 344.4K +277.3K (+413.4%) | 14.50M +12.2M (+530.1%) | 0.44% +0.352 pp | 0.00% +0.002 pp | USD40.42 +4.2% | 48 qtrs — |
| 49 | CASDIN CAPITAL, LLC | 276.3K +— (+0.0%) | 11.63M +2.1M (+22.6%) | 0.35% -0.002 pp | 0.72% -0.068 pp | USD21.64 +94.5% | 8 qtrs — |
| 50 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 273.6K -33.3K (-10.8%) | 11.52M +983.5K (+9.3%) | 0.35% -0.045 pp | 0.04% +0.000 pp | USD34.33 +22.6% | 2 qtrs — |
| 51 | JANUS HENDERSON GROUP PLC | 271.6K +237.3K (+691.3%) | 11.44M +10.3M (+870.0%) | 0.35% +0.301 pp | 0.01% +0.005 pp | USD40.91 +2.9% | 18 qtrs — |
| 52 | NORDEA INVESTMENT MANAGEMENT AB | 237.7K -34.9K (-12.8%) | 10.13M +970.1K (+10.6%) | 0.30% -0.047 pp | 0.01% +0.001 pp | USD22.98 +83.2% | 10 qtrs — |
| 53 | SUMMIT CREEK ADVISORS LLC | 238.5K -9.6K (-3.9%) | 10.04M +1.5M (+17.9%) | 0.30% -0.014 pp | 1.58% +0.338 pp | USD34.33 +22.6% | 2 qtrs — |
| 54 | BARCLAYS PLC | 211.7K +65.3K (+44.6%) | 8.91M +3.9M (+78.8%) | 0.27% +0.082 pp | 0.00% +0.001 pp | USD32.57 +29.3% | 38 qtrs — |
| 55 | RHUMBLINE ADVISERS | 211.1K -11.1K (-5.0%) | 8.89M +1.3M (+16.5%) | 0.27% -0.016 pp | 0.01% +0.001 pp | USD29.20 +44.2% | 43 qtrs — |
| 56 | FRANKLIN RESOURCES INC | 209.5K +1.5K (+0.7%) | 8.82M +1.7M (+23.5%) | 0.27% +0.000 pp | 0.00% +0.000 pp | USD23.61 +78.3% | 11 qtrs — |
| 57 | UBS ASSET MANAGEMENT AMERICAS INC | 198.0K -2.4K (-1.2%) | 8.34M +1.5M (+21.2%) | 0.25% -0.005 pp | 0.00% +0.000 pp | USD28.54 +47.5% | 27 qtrs — |
| 58 | BLAIR WILLIAM & CO/IL | 191.7K +176.3K (+1,144.1%) | 8.07M +7.5M (+1,425.7%) | 0.24% +0.224 pp | 0.02% +0.020 pp | USD41.07 +2.5% | 33 qtrs — |
| 59 | UBS GROUP AG | 172.5K -92.0K (-34.8%) | 7.26M -1.8M (-20.0%) | 0.22% -0.119 pp | 0.00% 0.000 pp | USD31.39 +34.1% | 45 qtrs — |
| 60 | WALLEYE CAPITAL LLC | 165.6K +133.9K (+422.2%) | 6.97M +5.9M (+540.4%) | 0.21% +0.170 pp | 0.02% +0.017 pp | USD40.61 +3.7% | 2 qtrs — |
| 61 | PALISADES INVESTMENT PARTNERS, LLC | 162.0K +3.9K (+2.5%) | 6.82M +1.4M (+25.7%) | 0.21% +0.004 pp | 2.58% +0.446 pp | USD39.47 +6.7% | 5 qtrs — |
| 62 | CITADEL ADVISORS LLC | 159.7K -318.2K (-66.6%) | 6.72M -9.7M (-59.0%) | 0.20% -0.408 pp | 0.00% -0.002 pp | USD27.92 +50.8% | 37 qtrs — |
| 63 | SWISS NATIONAL BANK | 155.2K +3.4K (+2.2%) | 6.53M +1.3M (+25.4%) | 0.20% +0.003 pp | 0.00% +0.001 pp | USD31.93 +31.9% | 27 qtrs — |
| 64 | IQ EQ FUND MANAGEMENT (IRELAND) LTD | 154.6K +15.5K (+11.1%) | 6.51M +1.7M (+36.3%) | 0.20% +0.019 pp | 0.45% +0.126 pp | USD33.12 +27.1% | 6 qtrs — |
| 65 | PRUDENTIAL FINANCIAL INC | 148.9K -13.4K (-8.3%) | 6.27M +697.0K (+12.5%) | 0.19% -0.018 pp | 0.01% +0.001 pp | USD33.47 +25.8% | 22 qtrs — |
| 66 | AMERIPRISE FINANCIAL INC | 142.3K -9.4K (-6.2%) | 5.99M +782.0K (+15.0%) | 0.18% -0.013 pp | 0.00% +0.000 pp | USD34.33 +22.6% | 6 qtrs — |
| 67 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 138.1K +15.5K (+12.6%) | 5.82M +1.6M (+38.3%) | 0.18% +0.019 pp | 0.01% +0.003 pp | USD38.41 +9.6% | 5 qtrs — |
| 68 | ALLIANZ ASSET MANAGEMENT GMBH | 135.7K +1.6K (+1.2%) | 5.71M +1.1M (+24.1%) | 0.17% +0.001 pp | 0.01% +0.001 pp | USD36.72 +14.7% | 6 qtrs — |
| 69 | — | 133.0K +133.0K (+100.0%) | 5.60M +5.6M (+100.0%) | 0.17% +0.169 pp | 0.11% +0.108 pp | USD42.10 +0.0% | 1 qtrs NEW |
| 70 | PANAGORA ASSET MANAGEMENT INC | 131.7K +5.6K (+4.4%) | 5.54M +1.2M (+28.0%) | 0.17% +0.006 pp | 0.02% +0.002 pp | USD37.01 +13.8% | 6 qtrs — |
| 71 | CI PRIVATE WEALTH, LLC | 130.0K +130.0K (+100.0%) | 5.47M +5.5M (+100.0%) | 0.17% +0.165 pp | 0.01% +0.007 pp | USD42.10 +0.0% | 13 qtrs — |
| 72 | CAPTION MANAGEMENT, LLC | 129.5K +129.5K (+100.0%) | 5.45M +5.5M (+100.0%) | 0.16% +0.165 pp | 0.04% +0.037 pp | USD42.10 +0.0% | 1 qtrs NEW |
| 73 | AMUNDI | 128.7K -33.0K (-20.4%) | 5.42M -410.2K (-7.0%) | 0.16% -0.043 pp | 0.00% 0.000 pp | USD34.33 +22.6% | 2 qtrs — |
| 74 | ARDSLEY ADVISORY PARTNERS LP | 125.0K +125.0K (+100.0%) | 5.26M +5.3M (+100.0%) | 0.16% +0.159 pp | 0.58% +0.578 pp | USD42.10 +0.0% | 1 qtrs NEW |
| 75 | MERCER GLOBAL ADVISORS INC /ADV | 123.9K +147.0 (+0.1%) | 5.22M +967.6K (+22.8%) | 0.16% -0.001 pp | 0.01% +0.001 pp | USD21.54 +95.5% | 15 qtrs — |
| 76 | BROWN CAPITAL MANAGEMENT LLC | 114.2K +114.2K (+100.0%) | 4.81M +4.8M (+100.0%) | 0.15% +0.145 pp | 0.39% +0.394 pp | USD42.10 +0.0% | 1 qtrs NEW |
| 77 | EXCHANGE TRADED CONCEPTS, LLC | 110.9K -21.5K (-16.2%) | 4.67M +124.3K (+2.7%) | 0.14% -0.028 pp | 0.04% -0.003 pp | USD29.33 +43.5% | 25 qtrs — |
| 78 | RICE HALL JAMES & ASSOCIATES, LLC | 108.1K -19.1K (-15.0%) | 4.55M +184.0K (+4.2%) | 0.14% -0.025 pp | 0.25% +0.012 pp | USD32.66 +28.9% | 6 qtrs — |
| 79 | ALLIANCEBERNSTEIN L.P. | 102.2K +8.3K (+8.9%) | 4.30M +1.1M (+33.5%) | 0.13% +0.010 pp | 0.00% +0.000 pp | USD29.36 +43.4% | 31 qtrs — |
| 80 | PARKMAN HEALTHCARE PARTNERS LLC | 100.3K -122.8K (-55.0%) | 4.22M -3.4M (-44.9%) | 0.13% -0.158 pp | 0.40% -0.397 pp | USD28.48 +47.8% | 18 qtrs — |
| 81 | WELLS FARGO & COMPANY/MN | 98.5K +41.7K (+73.5%) | 4.15M +2.2M (+112.8%) | 0.13% +0.053 pp | 0.00% +0.000 pp | USD34.29 +22.8% | 49 qtrs — |
| 82 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 97.2K -1.4K (-1.4%) | 4.09M +711.1K (+21.0%) | 0.12% -0.003 pp | 0.01% +0.001 pp | USD21.33 +97.4% | 7 qtrs — |
| 83 | MILLENNIUM MANAGEMENT LLC | 89.9K +78.0K (+657.3%) | 3.78M +3.4M (+828.7%) | 0.11% +0.099 pp | 0.00% +0.001 pp | USD40.16 +4.8% | 49 qtrs — |
| 84 | RAFFERTY ASSET MANAGEMENT, LLC | 86.4K -8.2K (-8.6%) | 3.64M +391.2K (+12.1%) | 0.11% -0.011 pp | 0.01% +0.002 pp | USD25.95 +62.2% | 28 qtrs — |
| 85 | PERKINS CAPITAL MANAGEMENT INC | 75.4K -4.3K (-5.3%) | 3.18M +440.2K (+16.1%) | 0.10% -0.006 pp | 2.52% +0.111 pp | USD31.98 +31.6% | 22 qtrs — |
| 86 | DEUTSCHE BANK AG\ | 75.0K +2.1K (+2.9%) | 3.16M +654.4K (+26.1%) | 0.10% +0.002 pp | 0.00% +0.000 pp | USD32.93 +27.8% | 45 qtrs — |
| 87 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 74.8K -69.0 (-0.1%) | 3.15M +578.6K (+22.5%) | 0.10% -0.001 pp | 0.00% +0.001 pp | USD25.82 +63.1% | 49 qtrs — |
| 88 | PRICE T ROWE ASSOCIATES INC /MD/ | 74.7K +5.9K (+8.5%) | 3.14M +782.0K (+33.1%) | 0.09% +0.007 pp | 0.00% +0.000 pp | USD32.28 +30.4% | 26 qtrs — |
| 89 | VESTMARK ADVISORY SOLUTIONS, INC. | 74.3K -15.0K (-16.8%) | 3.13M +62.5K (+2.0%) | 0.09% -0.020 pp | 0.04% -0.016 pp | USD27.66 +52.2% | 9 qtrs — |
| 90 | RUSSELL INVESTMENTS GROUP, LTD. | 73.0K +61.0 (+0.1%) | 3.07M +569.1K (+22.7%) | 0.09% -0.001 pp | 0.00% +0.001 pp | USD34.20 +23.1% | 12 qtrs — |
| 91 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 71.8K -16.5K (-18.7%) | 3.02M +56.0K (+1.9%) | 0.09% -0.022 pp | 0.01% +0.001 pp | USD31.69 +32.8% | 27 qtrs — |
| 92 | GOTHAM ASSET MANAGEMENT, LLC | 69.6K +47.2K (+210.3%) | 2.93M +2.2M (+280.5%) | 0.09% +0.060 pp | 0.01% +0.007 pp | USD37.13 +13.4% | 15 qtrs — |
| 93 | ENVESTNET ASSET MANAGEMENT INC | 62.4K -29.7K (-32.3%) | 2.63M -535.6K (-16.9%) | 0.08% -0.039 pp | 0.00% 0.000 pp | USD25.75 +63.5% | 27 qtrs — |
| 94 | GREAT LAKES ADVISORS, LLC | 58.1K +— (+0.0%) | 2.44M +451.2K (+22.6%) | 0.07% -0.001 pp | 0.02% +0.003 pp | USD21.64 +94.5% | 8 qtrs — |
| 95 | ZACKS INVESTMENT MANAGEMENT | 56.1K +3.9K (+7.4%) | 2.36M +568.5K (+31.7%) | 0.07% +0.005 pp | 0.02% +0.004 pp | USD36.15 +16.5% | 6 qtrs — |
| 96 | THRIVENT FINANCIAL FOR LUTHERANS | 54.3K -2.4K (-4.3%) | 2.29M +339.0K (+17.4%) | 0.07% -0.004 pp | 0.00% +0.000 pp | USD34.33 +22.6% | 2 qtrs — |
| 97 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 53.3K -2.7K (-4.9%) | 2.24M +320.0K (+16.6%) | 0.07% -0.004 pp | 0.02% +0.002 pp | USD27.80 +51.4% | 13 qtrs — |
| 98 | PINNACLE ASSOCIATES LTD | 52.6K -542.0 (-1.0%) | 2.21M +390.2K (+21.4%) | 0.07% -0.001 pp | 0.03% +0.004 pp | USD29.64 +42.0% | 4 qtrs — |
| 99 | COMERICA BANK | 52.1K +22.4K (+75.5%) | 2.19M +1.2M (+115.2%) | 0.07% +0.028 pp | 0.01% +0.005 pp | USD37.54 +12.1% | 11 qtrs — |
| 100 | LOS ANGELES CAPITAL MANAGEMENT LLC | 55.0K -130.0 (-0.2%) | 1.94M +50.6K (+2.7%) | 0.07% -0.001 pp | 0.01% +0.000 pp | USD29.46 +42.9% | 9 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.79
Neutral
Ratio by volume
2.84
Bullish
Buys
15
Sells
19
Shares acquired
658.5K
Shares disposed
231.5K
Cash buys
—
Cash sales
8.00
Net activity
+426,956
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-10 | Haas Kevin Richard | Officer | A-Award | A | Common Stock | 44,221 | 0.00 | — | 44,221 | D | ↗ |
| 2026-03-24 | Haas Kevin Richard | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-06 | Wygant Jonathan | Officer | A-Award | A | Common Stock | 10,525 | 0.00 | — | 45,434 | D | ↗ |
| 2026-03-06 | Stapley Marc | Director / Officer | A-Award | A | Common Stock | 92,099 | 0.00 | — | 449,653 | D | ↗ |
| 2026-03-06 | McGuire Annie | Officer | A-Award | A | Common Stock | 32,892 | 0.00 | — | 127,598 | D | ↗ |
| 2026-03-06 | Leite John | Officer | A-Award | A | Common Stock | 36,181 | 0.00 | — | 143,761 | D | ↗ |
| 2026-03-06 | Febbo Phillip G. | Officer | A-Award | A | Common Stock | 29,603 | 0.00 | — | 146,949 | D | ↗ |
| 2026-03-06 | Chambers Rebecca | Officer | A-Award | A | Common Stock | 36,181 | 0.00 | — | 167,377 | D | ↗ |
| 2026-03-04 | Stapley Marc | Director / Officer | S-Sale | D | Common Stock | 19,244 | 35.56 | 684.2K | 383,833 | D | ↗ |
| 2026-03-04 | McGuire Annie | Officer | S-Sale | D | Common Stock | 4,994 | 35.29 | 176.3K | 96,370 | D | ↗ |
| 2026-03-04 | Leite John | Officer | S-Sale | D | Common Stock | 5,260 | 35.19 | 185.1K | 107,580 | D | ↗ |
| 2026-03-04 | Chambers Rebecca | Officer | S-Sale | D | Common Stock | 4,400 | 35.55 | 156.4K | 145,137 | D | ↗ |
| 2026-03-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 3,006 | 36.01 | 108.2K | 34,909 | D | ↗ |
| 2026-03-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 19,455 | 36.01 | 700.6K | 403,077 | D | ↗ |
| 2026-03-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 6,902 | 36.01 | 248.5K | 101,364 | D | ↗ |
| 2026-03-02 | Leite John | Officer | F-InKind | D | Common Stock | 7,517 | 36.01 | 270.7K | 112,840 | D | ↗ |
| 2026-03-02 | Febbo Phillip G. | Officer | S-Sale | D | Common Stock | 13,425 | 36.16 | 485.4K | 117,346 | D | ↗ |
| 2026-03-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 7,234 | 36.01 | 260.5K | 149,537 | D | ↗ |
| 2026-02-26 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 35,841 | 38.75 | 1.39M | 422,532 | D | ↗ |
| 2026-02-26 | McGuire Annie | Officer | F-InKind | D | Common Stock | 10,867 | 38.75 | 421.1K | 108,266 | D | ↗ |
| 2026-02-26 | Leite John | Officer | F-InKind | D | Common Stock | 8,905 | 38.75 | 345.1K | 120,357 | D | ↗ |
| 2026-02-26 | Febbo Phillip G. | Officer | F-InKind | D | Common Stock | 24,486 | 38.75 | 948.8K | 136,806 | D | ↗ |
| 2026-02-26 | Chambers Rebecca | Officer | A-Award | A | Common Stock | 59,324 | 0.00 | — | 168,820 | D | ↗ |
| 2025-12-16 | McGuire Annie | Officer | S-Sale | D | Common Stock | 10,639 | 43.13 | 458.8K | 67,860 | D | ↗ |
| 2025-12-05 | EASTHAM KARIN | Director | S-Sale | D | Common Stock | 800 | 46.59 | 37.3K | 13,554 | D | ↗ |
| 2025-12-04 | Stapley Marc | Director / Officer | S-Sale | D | Common Stock | 4,448 | 46.90 | 208.6K | 321,823 | D | ↗ |
| 2025-12-04 | McGuire Annie | Officer | S-Sale | D | Common Stock | 720 | 47.10 | 33.9K | 79,201 | D | ↗ |
| 2025-12-04 | Leite John | Officer | S-Sale | D | Common Stock | 1,278 | 47.51 | 60.7K | 82,113 | D | ↗ |
| 2025-12-04 | Chambers Rebecca | Officer | S-Sale | D | Common Stock | 8,537 | 46.61 | 397.9K | 114,237 | D | ↗ |
| 2025-12-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 1,325 | 46.16 | 61.2K | 37,420 | D | ↗ |
| 2025-12-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 7,914 | 46.16 | 365.3K | 326,271 | D | ↗ |
| 2025-12-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 3,052 | 46.16 | 140.9K | 79,921 | D | ↗ |
| 2025-12-02 | Leite John | Officer | F-InKind | D | Common Stock | 2,900 | 46.16 | 133.9K | 83,391 | D | ↗ |
| 2025-12-02 | Febbo Phillip G. | Officer | F-InKind | D | Common Stock | 2,955 | 46.16 | 136.4K | 89,486 | D | ↗ |
| 2025-12-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 3,384 | 46.16 | 156.2K | 122,774 | D | ↗ |
| 2025-11-25 | Leite John | Officer | S-Sale | D | Common Stock | 2,808 | 50.00 | 140.4K | 86,291 | D | ↗ |
| 2025-11-25 | JONES EVAN/ FA | Director | S-Sale | D | Common Stock | 1,106 | 50.25 | 55.6K | 29,362 | D | ↗ |
| 2025-11-20 | Holstein Jens | Director | S-Sale | D | Common Stock | 1,460 | 43.21 | 63.1K | 27,199 | D | ↗ |
| 2025-11-10 | Wygant Jonathan | Officer | S-Sale | D | Common Stock | 5,102 | 42.33 | 216.0K | 38,745 | D | ↗ |
| 2025-11-07 | Wygant Jonathan | Officer | S-Sale | D | Common Stock | 5,818 | 40.21 | 233.9K | 43,847 | D | ↗ |
| 2025-11-05 | McGuire Annie | Officer | S-Sale | D | Common Stock | 6,466 | 40.00 | 258.6K | 82,973 | D | ↗ |
| 2025-11-05 | JONES EVAN/ FA | Director | S-Sale | D | Common Stock | 5,872 | 45.07 | 264.6K | 55,421 | D | ↗ |
| 2025-11-05 | EASTHAM KARIN | Director | S-Sale | D | Common Stock | 9,674 | 40.02 | 387.2K | 13,554 | D | ↗ |
| 2025-11-05 | Chambers Rebecca | Officer | S-Sale | D | Common Stock | 7,000 | 41.00 | 287.0K | 126,158 | D | ↗ |
| 2025-10-28 | Wygant Jonathan | Officer | A-Award | A | Common Stock | 2,886 | 0.00 | — | 49,665 | D | ↗ |
| 2025-10-06 | Febbo Phillip G. | Officer | S-Sale | D | Common Stock | 8,349 | 36.02 | 300.7K | 92,441 | D | ↗ |
| 2025-10-01 | McGuire Annie | Officer | S-Sale | D | Common Stock | 2,160 | 35.00 | 75.6K | 89,439 | D | ↗ |
| 2025-10-01 | Leite John | Officer | S-Sale | D | Common Stock | 2,539 | 35.00 | 88.9K | 89,099 | D | ↗ |
| 2025-10-01 | EPSTEIN ROBERT S | Director | S-Sale | D | Common Stock | 21,473 | 35.08 | 753.2K | 62,446 | D | ↗ |
| 2025-09-19 | McGuire Annie | Officer | S-Sale | D | Common Stock | 2,283 | 33.69 | 76.9K | 91,599 | D | ↗ |
| 2025-09-04 | Stapley Marc | Director / Officer | S-Sale | D | Common Stock | 7,667 | 30.41 | 233.1K | 334,185 | D | ↗ |
| 2025-09-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 1,648 | 30.11 | 49.6K | 46,779 | D | ↗ |
| 2025-09-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 7,914 | 30.11 | 238.3K | 341,852 | D | ↗ |
| 2025-09-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 3,507 | 30.11 | 105.6K | 93,882 | D | ↗ |
| 2025-09-02 | Leite John | Officer | F-InKind | D | Common Stock | 2,902 | 30.11 | 87.4K | 91,638 | D | ↗ |
| 2025-09-02 | Febbo Phillip G. | Officer | F-InKind | D | Common Stock | 2,955 | 30.11 | 89.0K | 100,790 | D | ↗ |
| 2025-09-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 5,371 | 30.11 | 161.7K | 133,158 | D | ↗ |
| 2025-06-18 | Shafer David Brent | Director | A-Award | A | Common Stock | 9,321 | 0.00 | — | 25,828 | D | ↗ |
| 2025-06-18 | Miller Thomas F. | Director | A-Award | A | Common Stock | 9,321 | 0.00 | — | 25,828 | D | ↗ |
| 2025-06-18 | JONES EVAN/ FA | Director | A-Award | A | Common Stock | 9,321 | 0.00 | — | 43,664 | D | ↗ |
| 2025-06-18 | Holstein Jens | Director | A-Award | A | Common Stock | 9,321 | 0.00 | — | 37,199 | D | ↗ |
| 2025-06-18 | EPSTEIN ROBERT S | Director | A-Award | A | Common Stock | 9,321 | 0.00 | — | 73,919 | D | ↗ |
| 2025-06-18 | EASTHAM KARIN | Director | A-Award | A | Common Stock | 9,321 | 0.00 | — | 23,228 | D | ↗ |
| 2025-06-18 | Bhanji Muna | Director | A-Award | A | Common Stock | 9,321 | 0.00 | — | 39,310 | D | ↗ |
| 2025-06-18 | Barr Eliav | Director | A-Award | A | Common Stock | 9,321 | 0.00 | — | 51,189 | D | ↗ |
| 2025-06-13 | EASTHAM KARIN | Director | S-Sale | D | Common Stock | 4,590 | 26.66 | 122.4K | 13,907 | D | ↗ |
| 2025-06-13 | Bhanji Muna | Director | S-Sale | D | Common Stock | 4,589 | 26.67 | 122.4K | 29,989 | D | ↗ |
| 2025-06-04 | Leite John | Officer | S-Sale | D | Common Stock | 2,809 | 27.20 | 76.4K | 94,540 | D | ↗ |
| 2025-06-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 1,848 | 26.74 | 49.4K | 47,915 | D | ↗ |
| 2025-06-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 9,399 | 26.74 | 251.3K | 349,237 | D | ↗ |
| 2025-06-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 3,505 | 26.74 | 93.7K | 97,003 | D | ↗ |
| 2025-06-02 | Leite John | Officer | F-InKind | D | Common Stock | 2,900 | 26.74 | 77.5K | 97,349 | D | ↗ |
| 2025-06-02 | Febbo Phillip G. | Officer | F-InKind | D | Common Stock | 2,955 | 26.74 | 79.0K | 103,745 | D | ↗ |
| 2025-06-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 5,370 | 26.74 | 143.6K | 138,529 | D | ↗ |
| 2025-03-07 | Leite John | Officer | S-Sale | D | Common Stock | 2,400 | 31.04 | 74.5K | 105,260 | D | ↗ |
| 2025-03-06 | Wygant Jonathan | Officer | A-Award | A | Common Stock | 13,288 | 0.00 | — | 49,763 | D | ↗ |
| 2025-03-06 | Stapley Marc | Director / Officer | A-Award | A | Common Stock | 90,601 | 0.00 | — | 358,636 | D | ↗ |
| 2025-03-06 | McGuire Annie | Officer | A-Award | A | Common Stock | 30,200 | 0.00 | — | 100,508 | D | ↗ |
| 2025-03-06 | Leite John | Officer | A-Award | A | Common Stock | 36,240 | 0.00 | — | 107,660 | D | ↗ |
| 2025-03-06 | Febbo Phillip G. | Officer | A-Award | A | Common Stock | 24,160 | 0.00 | — | 106,700 | D | ↗ |
| 2025-03-06 | Chambers Rebecca | Officer | A-Award | A | Common Stock | 30,200 | 0.00 | — | 143,899 | D | ↗ |
| 2025-03-04 | Stapley Marc | Director / Officer | S-Sale | D | Common Stock | 1,094 | 34.37 | 37.6K | 268,035 | D | ↗ |
| 2025-03-04 | McGuire Annie | Officer | S-Sale | D | Common Stock | 1,142 | 33.69 | 38.5K | 70,308 | D | ↗ |
| 2025-03-04 | Febbo Phillip G. | Officer | S-Sale | D | Common Stock | 3,570 | 33.95 | 121.2K | 82,540 | D | ↗ |
| 2025-03-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 4,301 | 34.76 | 149.5K | 36,475 | D | ↗ |
| 2025-03-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 20,324 | 34.76 | 706.5K | 320,732 | D | ↗ |
| 2025-03-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 8,255 | 34.76 | 286.9K | 71,450 | D | ↗ |
| 2025-03-02 | Leite John | Officer | F-InKind | D | Common Stock | 7,650 | 34.76 | 265.9K | 71,420 | D | ↗ |
| 2025-03-02 | Febbo Phillip G. | Officer | F-InKind | D | Common Stock | 6,754 | 34.76 | 234.8K | 90,577 | D | ↗ |
| 2025-03-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 11,070 | 34.76 | 384.8K | 113,699 | D | ↗ |
| 2025-02-27 | Stapley Marc | Director / Officer | A-Award | A | Common Stock | 67,277 | 0.00 | — | 375,329 | D | ↗ |
| 2025-02-27 | McGuire Annie | Officer | A-Award | A | Common Stock | 13,466 | 0.00 | — | 86,705 | D | ↗ |
| 2025-02-27 | Leite John | Officer | S-Sale | D | Common Stock | 5,746 | 33.84 | 194.4K | 79,070 | D | ↗ |
| 2025-02-27 | Febbo Phillip G. | Officer | F-InKind | D | Common Stock | 15,672 | 33.84 | 530.3K | 97,331 | D | ↗ |
| 2025-02-27 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 11,911 | 33.84 | 403.1K | 124,769 | D | ↗ |
| 2025-02-03 | Chambers Rebecca | Officer | S-Sale | D | Common Stock | 527 | 43.85 | 23.1K | 113,510 | D | ↗ |
| 2025-01-06 | EPSTEIN ROBERT S | Director | M-Exempt | A | Common Stock | 20,000 | 8.04 | 160.8K | 64,598 | D | ↗ |
| 2025-01-02 | EASTHAM KARIN | Director | S-Sale | D | Common Stock | 4,691 | 40.50 | 190.0K | 18,497 | D | ↗ |
| 2024-12-13 | Stapley Marc | Director / Officer | S-Sale | D | Common Stock | 5,190 | 43.37 | 225.1K | 307,745 | D | ↗ |
| 2024-12-04 | McGuire Annie | Officer | S-Sale | D | Common Stock | 18,699 | 44.02 | 823.2K | 72,869 | D | ↗ |
| 2024-12-04 | Febbo Phillip G. | Officer | S-Sale | D | Common Stock | 3,934 | 44.09 | 173.4K | 82,414 | D | ↗ |
| 2024-12-03 | Wygant Jonathan | Officer | S-Sale | D | Common Stock | 956 | 43.36 | 41.5K | 40,270 | D | ↗ |
| 2024-12-03 | Leite John | Officer | S-Sale | D | Common Stock | 1,050 | 43.25 | 45.4K | 73,810 | D | ↗ |
| 2024-12-03 | Chambers Rebecca | Officer | S-Sale | D | Common Stock | 7,000 | 43.23 | 302.6K | 114,037 | D | ↗ |
| 2024-12-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 1,087 | 44.12 | 48.0K | 41,226 | D | ↗ |
| 2024-12-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 5,748 | 44.12 | 253.6K | 312,935 | D | ↗ |
| 2024-12-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 1,918 | 44.12 | 84.6K | 91,568 | D | ↗ |
| 2024-12-02 | Leite John | Officer | F-InKind | D | Common Stock | 1,314 | 44.12 | 58.0K | 74,860 | D | ↗ |
| 2024-12-02 | Febbo Phillip G. | Officer | F-InKind | D | Common Stock | 6,738 | 44.12 | 297.3K | 86,348 | D | ↗ |
| 2024-12-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 3,464 | 44.12 | 152.8K | 121,037 | D | ↗ |
| 2024-11-27 | Wygant Jonathan | Officer | S-Sale | D | Common Stock | 5,032 | 42.89 | 215.8K | 42,313 | D | ↗ |
| 2024-11-19 | EASTHAM KARIN | Director | S-Sale | D | Common Stock | 10,125 | 38.76 | 392.4K | 18,497 | D | ↗ |
| 2024-11-12 | EPSTEIN ROBERT S | Director | M-Exempt | A | Common Stock | 15,000 | 8.04 | 120.6K | 59,598 | D | ↗ |
| 2024-11-12 | Chambers Rebecca | Officer | S-Sale | D | Common Stock | 15,275 | 38.34 | 585.7K | 124,501 | D | ↗ |
| 2024-09-19 | JONES EVAN/ FA | Director | S-Sale | D | Common Stock | 5,173 | 35.23 | 182.3K | 0 | I | ↗ |
| 2024-09-04 | Leite John | Officer | S-Sale | D | Common Stock | 5,479 | 29.78 | 163.2K | 76,174 | — | ↗ |
| 2024-09-03 | Shafer David Brent | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-03 | Miller Thomas F. | Director | A-Award | A | Common Stock | 16,507 | 0.00 | — | 16,507 | — | ↗ |
| 2024-09-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 1,087 | 31.55 | 34.3K | 47,345 | — | ↗ |
| 2024-09-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 5,748 | 31.55 | 181.3K | 318,683 | — | ↗ |
| 2024-09-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 1,920 | 31.55 | 60.6K | 93,486 | — | ↗ |
| 2024-09-02 | Leite John | Officer | F-InKind | D | Common Stock | 1,315 | 31.55 | 41.5K | 81,653 | — | ↗ |
| 2024-09-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 3,464 | 31.55 | 109.3K | 139,776 | — | ↗ |
| 2024-08-13 | JONES EVAN/ FA | Director | S-Sale | D | Common Stock | 22,407 | 32.36 | 725.0K | 6,085 | — | ↗ |
| 2024-08-12 | JONES EVAN/ FA | Director | S-Sale | D | Common Stock | 101 | 30.01 | 3.0K | 32,361 | — | ↗ |
| 2024-08-09 | JONES EVAN/ FA | Director | M-Exempt | A | Common Stock | 300 | 10.41 | 3.1K | 47,445 | — | ↗ |
| 2024-08-07 | JONES EVAN/ FA | Director | M-Exempt | D | Stock Option (right to buy) | 1,214 | 10.41 | 12.6K | 8,786 | — | ↗ |
| 2024-08-07 | Holstein Jens | Director | S-Sale | D | Common Stock | 2,500 | 30.00 | 75.0K | 27,878 | — | ↗ |
| 2024-07-16 | Leite John | Officer | S-Sale | D | Common Stock | 1,277 | 25.00 | 31.9K | 82,968 | — | ↗ |
| 2024-07-16 | Holstein Jens | Director | S-Sale | D | Common Stock | 2,500 | 24.00 | 60.0K | 35,378 | — | ↗ |
| 2024-07-16 | EASTHAM KARIN | Director | S-Sale | D | Common Stock | 7,500 | 25.00 | 187.5K | 33,228 | — | ↗ |
| 2024-06-13 | JONES EVAN/ FA | Director | A-Award | A | Common Stock | 11,473 | 0.00 | — | 49,074 | — | ↗ |
| 2024-06-13 | Holstein Jens | Director | A-Award | A | Common Stock | 11,473 | 0.00 | — | 37,878 | — | ↗ |
| 2024-06-13 | EPSTEIN ROBERT S | Director | A-Award | A | Common Stock | 11,473 | 0.00 | — | 44,598 | — | ↗ |
| 2024-06-13 | EASTHAM KARIN | Director | A-Award | A | Common Stock | 11,473 | 0.00 | — | 40,728 | — | ↗ |
| 2024-06-13 | Bhanji Muna | Director | A-Award | A | Common Stock | 11,473 | 0.00 | — | 34,578 | — | ↗ |
| 2024-06-13 | Barr Eliav | Director | A-Award | A | Common Stock | 11,473 | 0.00 | — | 41,868 | — | ↗ |
| 2024-06-11 | EASTHAM KARIN | Director | S-Sale | D | Common Stock | 3,870 | 20.59 | 79.7K | 29,255 | — | ↗ |
| 2024-06-10 | Bhanji Muna | Director | S-Sale | D | Common Stock | 3,870 | 20.32 | 78.6K | 23,105 | — | ↗ |
| 2024-06-07 | EASTHAM KARIN | Director | M-Exempt | A | Common Stock | 2,500 | 10.41 | 26.0K | 35,625 | — | ↗ |
| 2024-06-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 1,087 | 20.75 | 22.6K | 47,971 | — | ↗ |
| 2024-06-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 5,746 | 20.75 | 119.2K | 323,994 | — | ↗ |
| 2024-06-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 1,919 | 20.75 | 39.8K | 95,406 | — | ↗ |
| 2024-06-02 | Leite John | Officer | F-InKind | D | Common Stock | 1,314 | 20.75 | 27.3K | 84,245 | — | ↗ |
| 2024-06-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 3,462 | 20.75 | 71.8K | 143,240 | — | ↗ |
| 2024-05-28 | Bhanji Muna | Director | S-Sale | D | Common Stock | 1,539 | 21.00 | 32.3K | 26,975 | — | ↗ |
| 2024-04-01 | EASTHAM KARIN | Director | M-Exempt | A | Common Stock | 10,000 | 13.19 | 131.9K | 43,125 | — | ↗ |
| 2024-03-15 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 5,971 | 21.10 | 126.0K | 329,740 | — | ↗ |
| 2024-03-15 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 2,189 | 21.10 | 46.2K | 146,702 | — | ↗ |
| 2024-03-06 | Wygant Jonathan | Officer | A-Award | A | Common Stock | 23,942 | 0.00 | — | 49,058 | — | ↗ |
| 2024-03-06 | Stapley Marc | Director / Officer | A-Award | A | Common Stock | 114,724 | 0.00 | — | 323,931 | — | ↗ |
| 2024-03-06 | McGuire Annie | Officer | A-Award | A | Common Stock | 49,880 | 0.00 | — | 97,325 | — | ↗ |
| 2024-03-06 | Leite John | Officer | A-Award | A | Common Stock | 49,880 | 0.00 | — | 85,559 | — | ↗ |
| 2024-03-06 | Febbo Phillip G. | Officer | A-Award | A | Common Stock | 39,904 | 0.00 | — | 93,086 | — | ↗ |
| 2024-03-06 | Chambers Rebecca | Officer | A-Award | A | Common Stock | 59,856 | 0.00 | — | 144,573 | — | ↗ |
| 2024-03-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 2,337 | 24.00 | 56.1K | 25,116 | — | ↗ |
| 2024-03-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 13,286 | 24.00 | 318.9K | 209,207 | — | ↗ |
| 2024-03-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 4,347 | 24.00 | 104.3K | 47,445 | — | ↗ |
| 2024-03-02 | Leite John | Officer | F-InKind | D | Common Stock | 3,008 | 24.00 | 72.2K | 35,679 | — | ↗ |
| 2024-03-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 6,112 | 24.00 | 146.7K | 84,717 | — | ↗ |
| 2024-03-01 | JONES EVAN/ FA | Director | M-Exempt | A | Common Stock | 10,000 | 13.19 | 131.9K | 47,601 | — | ↗ |
| 2023-12-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 507 | 26.54 | 13.5K | 27,020 | — | ↗ |
| 2023-12-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 3,203 | 26.54 | 85.0K | 221,882 | — | ↗ |
| 2023-12-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 803 | 26.54 | 21.3K | 51,792 | — | ↗ |
| 2023-12-02 | Leite John | Officer | F-InKind | D | Common Stock | 556 | 26.54 | 14.8K | 38,687 | — | ↗ |
| 2023-12-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 1,800 | 26.54 | 47.8K | 90,829 | — | ↗ |
| 2023-10-02 | Febbo Phillip G. | Officer | A-Award | A | Stock Option (right to buy) | 85,858 | 21.96 | 1.89M | 85,858 | — | ↗ |
| 2023-09-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 1,247 | 26.70 | 33.3K | 27,527 | — | ↗ |
| 2023-09-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 3,204 | 26.70 | 85.5K | 225,085 | — | ↗ |
| 2023-09-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 1,729 | 26.70 | 46.2K | 52,595 | — | ↗ |
| 2023-09-02 | Leite John | Officer | F-InKind | D | Common Stock | 2,222 | 26.70 | 59.3K | 39,243 | — | ↗ |
| 2023-09-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 3,652 | 26.70 | 97.5K | 92,629 | — | ↗ |
| 2023-09-01 | Leite John | Officer | — | D | Common Stock | 0 | 0.00 | — | 41,465 | — | ↗ |
| 2023-07-19 | JONES EVAN/ FA | Director | S-Sale | D | Common Stock | 838 | 30.14 | 25.3K | 37,601 | — | ↗ |
| 2023-07-18 | JONES EVAN/ FA | Director | S-Sale | D | Common Stock | 7,441 | 30.19 | 224.6K | 38,263 | — | ↗ |
| 2023-07-18 | BISHOP JOHN L | Director | M-Exempt | A | Common Stock | 10,000 | 6.37 | 63.7K | 43,125 | — | ↗ |
| 2023-07-17 | JONES EVAN/ FA | Director | S-Sale | D | Common Stock | 19,095 | 30.07 | 574.1K | 40,763 | — | ↗ |
| 2023-07-17 | BISHOP JOHN L | Director | M-Exempt | D | Stock Option (right to buy) | 10,000 | 6.37 | 63.7K | 25,000 | — | ↗ |
| 2023-06-16 | Bhanji Muna | Director | S-Sale | D | Common Stock | 100 | 27.09 | 2.7K | 28,514 | — | ↗ |
| 2023-06-09 | JONES EVAN/ FA | Director | A-Award | A | Common Stock | 9,674 | 0.00 | — | 59,858 | — | ↗ |
| 2023-06-09 | Holstein Jens | Director | A-Award | A | Common Stock | 9,674 | 0.00 | — | 26,405 | — | ↗ |
| 2023-06-09 | EPSTEIN ROBERT S | Director | A-Award | A | Common Stock | 9,674 | 0.00 | — | 33,125 | — | ↗ |
| 2023-06-09 | EASTHAM KARIN | Director | A-Award | A | Common Stock | 9,674 | 0.00 | — | 33,125 | — | ↗ |
| 2023-06-09 | Bhanji Muna | Director | A-Award | A | Common Stock | 9,674 | 0.00 | — | 34,407 | — | ↗ |
| 2023-06-09 | Barr Eliav | Director | A-Award | A | Common Stock | 9,674 | 0.00 | — | 30,395 | — | ↗ |
| 2023-06-09 | BISHOP JOHN L | Director | A-Award | A | Common Stock | 9,674 | 0.00 | — | 33,125 | — | ↗ |
| 2023-06-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 260 | 26.72 | 6.9K | 28,354 | — | ↗ |
| 2023-06-02 | Stapley Marc | Director / Officer | F-InKind | D | Common Stock | 3,203 | 26.72 | 85.6K | 227,696 | — | ↗ |
| 2023-06-02 | McGuire Annie | Officer | F-InKind | D | Common Stock | 494 | 26.72 | 13.2K | 54,324 | — | ↗ |
| 2023-06-02 | Chambers Rebecca | Officer | F-InKind | D | Common Stock | 1,183 | 26.72 | 31.6K | 95,754 | — | ↗ |
| 2023-06-02 | Anderson Bonnie H | Director | F-InKind | D | Common Stock | 1,304 | 26.72 | 34.8K | 41,377 | — | ↗ |
| 2023-05-30 | Bhanji Muna | Director | S-Sale | D | Common Stock | 1,539 | 25.91 | 39.9K | 24,733 | — | ↗ |
| 2023-04-14 | Anderson Bonnie H | Director | S-Sale | D | Common Stock | 34,000 | 22.04 | 749.4K | 42,681 | — | ↗ |
| 2023-03-16 | EASTHAM KARIN | Director | M-Exempt | D | Stock Option (right to buy) | 18,750 | 12.12 | 227.3K | 0 | — | ↗ |
| 2023-03-15 | Anderson Bonnie H | Director | M-Exempt | A | Common Stock | 34,000 | 5.61 | 190.7K | 87,967 | — | ↗ |
| 2023-03-06 | Wygant Jonathan | Officer | A-Award | A | Common Stock | 8,868 | 0.00 | — | 28,614 | — | ↗ |
| 2023-03-06 | Stapley Marc | Director / Officer | A-Award | A | Stock Option (right to buy) | 128,869 | 23.73 | 3.06M | 128,869 | — | ↗ |
| 2023-03-06 | McGuire Annie | Officer | A-Award | A | Stock Option (right to buy) | 38,660 | 23.73 | 917.4K | 38,660 | — | ↗ |
| 2023-03-06 | Chambers Rebecca | Officer | A-Award | A | Common Stock | 26,014 | 0.00 | — | 96,937 | — | ↗ |
| 2023-03-02 | Wygant Jonathan | Officer | F-InKind | D | Common Stock | 1,224 | 24.10 | 29.5K | 19,746 | — | ↗ |
Executive team
Top executives
EBIT / Employee
90.3K
Shares Outstanding
79.79M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Marc Stapley Chief Executive Officer | 700.0K | — | 5.89M | — | 826.0K | 5.0K | 7.42M | 79.37% | ↗ |
| 2 | 2025 | John Leite Global Chief Commercial Officer | 510.3K | — | 2.36M | — | 331.2K | 5.0K | 3.20M | 73.57% | ↗ |
| 3 | 2025 | Rebecca Chambers Chief Financial Officer | 550.0K | — | 1.96M | — | 357.0K | 5.0K | 2.88M | 68.29% | ↗ |
| 4 | 2025 | Annie McGuire General Counsel and Head of Market Access | 500.0K | — | 1.96M | — | 324.5K | 5.0K | 2.79M | 70.30% | ↗ |
| 5 | 2025 | Phillip Febbo Chief Scientific Officer and Chief Medical Officer | 561.0K | — | 1.57M | — | 364.1K | 5.0K | 2.50M | 62.81% | ↗ |
| 6 | 2024 | Marc Stapley Chief Executive Officer | 675.0K | — | 5.13M | — | 1.01M | 3.0K | 6.82M | 75.20% | ↗ |
| 7 | 2024 | Rebecca Chambers Chief Financial Officer | 530.4K | — | 2.67M | — | 437.6K | 3.0K | 3.65M | 73.36% | ↗ |
| 8 | 2024 | John Leite Global Chief Commercial Officer | 472.5K | — | 2.23M | — | 389.8K | 3.0K | 3.09M | 72.03% | ↗ |
| 9 | 2024 | Annie McGuire General Counsel and Chief People Officer | 470.8K | — | 2.23M | — | 388.4K | 3.0K | 3.09M | 72.10% | ↗ |
| 10 | 2024 | Annie McGuire General Counsel and Head of Market Access | 470.8K | — | 2.23M | — | 388.4K | 3.0K | 3.09M | 72.10% | ↗ |
| 11 | 2024 | Phillip Febbo Chief Scientific and Chief Medical Officer | 550.0K | — | 1.78M | — | 453.8K | 3.0K | 2.79M | 63.91% | ↗ |
| 12 | 2024 | Phillip Febbo Chief Scientific Officer and Chief Medical Officer | 550.0K | — | 1.78M | — | 453.8K | 3.0K | 2.79M | 63.91% | ↗ |
| 13 | 2023 | Marc Stapley Chief Executive Officer | 650.0K | — | 3.70M | 1.93M | 900.3K | 3.0K | 7.18M | 78.38% | ↗ |
| 14 | 2023 | Phillip Febbo Chief Scientific and Chief Medical Officer | 137.5K | — | 2.34M | 1.21M | 104.7K | 3.0K | 3.79M | 93.52% | ↗ |
| 15 | 2023 | Phillip Febbo Chief Scientific Officer and Chief Medical Officer | 137.5K | — | 2.34M | 1.21M | 104.7K | 3.0K | 3.79M | 93.52% | ↗ |
| 16 | 2023 | Rebecca Chambers Chief Financial Officer | 510.0K | — | 1.23M | 642.5K | 388.5K | 3.0K | 2.78M | 67.56% | ↗ |
| 17 | 2023 | Annie McGuire General Counsel and Head of Market Access | 440.0K | — | 1.11M | 578.2K | 335.2K | 16.6K | 2.48M | 68.09% | ↗ |
| 18 | 2023 | Annie McGuire General Counsel and Chief People Officer | 440.0K | — | 1.11M | 578.2K | 335.2K | 16.6K | 2.48M | 68.09% | ↗ |
| 19 | 2023 | John Leite Global Chief Commercial Officer | 421.1K | — | 858.1K | 377.9K | 264.4K | 3.0K | 1.92M | 64.22% | ↗ |
| 20 | 2022 | Marc Stapley Chief Executive Officer Chief Financial Officer Chief Scientific and Chief Medical Officer Chief Commercial Officer, CLIA General Counsel and Chief People Officer | 625.0K | 9.25M | — | — | — | — | 9.87M | 0.00% | ↗ |
| 21 | 2022 | Marc Stapley Chief Executive Officer | 625.0K | — | 2.21M | 1.48M | 625.0K | 3.0K | 4.94M | 74.61% | ↗ |
| 22 | 2022 | Marc Stapley Chief Executive Officer Chief Financial Officer Former Global Chief Scientific and Chief Medical Officer General Counsel and Chief People Officer General Manager, Decipher Urologic Cancers | 625.0K | — | 2.21M | 1.48M | 625.0K | 3.0K | 4.94M | 74.61% | ↗ |
| 23 | 2022 | Rebecca Chambers Chief Financial Officer | 463.5K | — | 1.41M | 1.14M | 305.9K | 3.0K | 3.32M | 76.75% | ↗ |
| 24 | 2022 | Annie McGuire General Counsel and Chief People Officer | 334.9K | — | 934.0K | 946.4K | 154.0K | 77.8K | 2.45M | 76.84% | ↗ |
| 25 | 2021 | Marc Stapley Chief Executive Officer Chief Financial Officer Chief Scientific and Chief Medical Officer Chief Commercial Officer, CLIA General Counsel and Chief People Officer | 350.0K | 11.13M | — | — | — | — | 11.48M | 0.00% | ↗ |
| 26 | 2021 | Marc Stapley Chief Executive Officer Chief Financial Officer Former Global Chief Scientific and Chief Medical Officer General Counsel and Chief People Officer General Manager, Decipher Urologic Cancers | 350.0K | — | 2.57M | 2.52M | 297.5K | 3.0K | 5.74M | 88.67% | ↗ |
| 27 | 2021 | Marc Stapley Chief Executive Officer Vice President, Accounting | 350.0K | — | 2.57M | 2.52M | 297.5K | 3.0K | 5.74M | 88.67% | ↗ |
| 28 | 2021 | Jane Alley Bonnie H. Anderson Co-Founder and Executive Chair Chief Financial Officer Former Executive Vice President and General Counsel Global Chief Scientific and Chief Medical Officer Chief Operating Officer and Chief Financial Officer | 650.0K | — | 2.16M | 1.15M | 552.5K | 3.0K | 4.52M | 73.32% | ↗ |
| 29 | 2020 | Jane Alley Bonnie H. Anderson Co-Founder and Executive Chair Chief Financial Officer Former Executive Vice President and General Counsel Global Chief Scientific and Chief Medical Officer Chief Operating Officer and Chief Financial Officer | 625.0K | — | 864.4K | 2.45M | 625.0K | 2.0K | 4.57M | 72.61% | ↗ |
| 30 | 2020 | Bonnie H. Anderson Chairman and Chief Executive Officer Chief Operating Officer and Chief Financial Officer Chief Scientific Officer and Chief Medical Officer Chief Commercial Officer Executive Vice President, General Counsel and Secretary | 625.0K | — | — | 2.45M | 625.0K | — | 4.57M | 53.70% | ↗ |
| 31 | 2019 | Bonnie H. Anderson Chairman and Chief Executive Officer | 580.0K | 75.4K | — | 2.39M | 504.6K | — | 4.16M | 57.51% | ↗ |
| 32 | 2019 | Bonnie H. Anderson Chairman and Chief Executive Officer Chief Operating Officer and Chief Financial Officer Chief Scientific Officer and Chief Medical Officer Chief Commercial Officer Executive Vice President, General Counsel and Secretary | 580.0K | 75.4K | — | 2.39M | 504.6K | — | 4.16M | 57.51% | ↗ |
| 33 | 2019 | Jane Alley Bonnie H. Anderson Co-Founder and Executive Chair Chief Financial Officer Former Executive Vice President and General Counsel Global Chief Scientific and Chief Medical Officer Chief Operating Officer and Chief Financial Officer | 580.0K | 75.4K | 606.3K | 2.39M | 504.6K | 2.0K | 4.16M | 72.08% | ↗ |
| 34 | 2019 | Keith Kennedy Chief Operating Officer, Chief Financial Officer and Secretary | 432.0K | 32.2K | — | 638.3K | 215.3K | — | 2.77M | 23.01% | ↗ |
| 35 | 2019 | Giulia C. Kennedy Chief Scientific Officer and Chief Medical Officer | 421.0K | 33.1K | — | 638.3K | 221.6K | — | 2.12M | 30.05% | ↗ |
| 36 | 2019 | John Hanna Chief Commercial Officer | 375.0K | 26.9K | — | 638.3K | 179.4K | — | 2.03M | 31.44% | ↗ |
| 37 | 2019 | Christopher M. Hall | 209.1K | — | — | — | — | — | 700.7K | 0.00% | ↗ |
| 38 | 2018 | Bonnie H. Anderson Chairman and Chief Executive Officer Chief Operating Officer and Chief Financial Officer Chief Scientific Officer and Chief Medical Officer Chief Commercial Officer Executive Vice President, General Counsel and Secretary | 550.0K | — | 897.0K | 688.6K | 514.3K | — | 2.83M | 56.00% | ↗ |
| 39 | 2018 | Bonnie H. Anderson Chairman and Chief Executive Officer | 550.0K | — | 897.0K | 688.6K | 514.3K | — | 2.83M | 56.00% | ↗ |
| 40 | 2018 | Christopher M. Hall Chief Operating Officer and President | 415.0K | — | 536.4K | 337.4K | 287.6K | — | 1.58M | 55.36% | ↗ |
| 41 | 2018 | Christopher M. Hall | 415.0K | — | 448.5K | 337.4K | 287.6K | — | 1.58M | 49.79% | ↗ |
| 42 | 2018 | Keith Kennedy Chief Financial Officer and Secretary | 400.0K | — | 360.6K | 236.4K | 266.2K | — | 1.47M | 40.72% | ↗ |
| 43 | 2018 | Keith Kennedy Chief Operating Officer, Chief Financial Officer and Secretary | 400.0K | — | 299.0K | 236.4K | 266.2K | — | 1.47M | 36.52% | ↗ |
| 44 | 2017 | Bonnie H. Anderson Chairman and Chief Executive Officer | 550.0K | — | — | 1.44M | 220.0K | — | 2.21M | 65.12% | ↗ |
| 45 | 2017 | Christopher M. Hall | 415.0K | — | — | 371.9K | 114.1K | — | 1.08M | 34.31% | ↗ |
| 46 | 2017 | Christopher M. Hall Chief Operating Officer and President | 415.0K | — | 181.0K | 371.9K | 114.1K | — | 1.08M | 51.01% | ↗ |
| 47 | 2017 | Keith Kennedy Chief Operating Officer, Chief Financial Officer and Secretary | 400.0K | — | — | 93.0K | 100.0K | — | 792.7K | 11.73% | ↗ |
| 48 | 2017 | Keith Kennedy Chief Financial Officer and Secretary | 400.0K | — | — | 93.0K | 100.0K | — | 792.7K | 11.73% | ↗ |
| 49 | 2016 | Bonnie H. Anderson Chairman and Chief Executive Officer | 500.0K | — | — | 677.8K | 292.5K | — | 1.47M | 46.04% | ↗ |
| 50 | 2016 | Bonnie H. Anderson Chairman, President and Chief Executive Officer | 1.47M | — | — | — | — | — | 1.47M | 0.00% | ↗ |
| 51 | 2016 | Christopher M. Hall Chief Operating Officer and President | 395.0K | — | — | 293.8K | 177.8K | — | 868.5K | 33.82% | ↗ |
| 52 | 2016 | Christopher M. Hall Chief Operating Officer | 866.5K | — | — | — | — | — | 866.5K | 0.00% | ↗ |
| 53 | 2016 | Shelly D. Guyer Former Chief Financial Officer | 822.9K | — | — | — | — | — | 822.9K | 0.00% | ↗ |
| 54 | 2016 | Keith S. Kennedy Chief Financial Officer | 793.2K | — | — | — | — | — | 793.2K | 0.00% | ↗ |
| 55 | 2016 | Keith Kennedy Chief Financial Officer and Secretary | 29.0K | — | 186.8K | 390.7K | — | — | 606.4K | 95.22% | ↗ |
| 56 | 2015 | Bonnie H. Anderson President and Chief Executive Officer | 457.0K | — | — | 1.21M | 200.0K | — | 1.87M | 64.86% | ↗ |
| 57 | 2015 | Bonnie H. Anderson Chairman, President and Chief Executive Officer | 1.87M | — | — | — | — | — | 1.87M | 0.00% | ↗ |
| 58 | 2015 | Christopher M. Hall Chief Operating Officer | 929.1K | — | — | — | — | — | 929.1K | 0.00% | ↗ |
| 59 | 2015 | Shelly D. Guyer Former Chief Financial Officer | 816.6K | — | — | — | — | — | 816.6K | 0.00% | ↗ |
| 60 | 2015 | Shelly D. Guyer Chief Financial Officer | 321.0K | — | — | 404.1K | 91.5K | — | 816.6K | 49.49% | ↗ |
| 61 | 2014 | Bonnie H. Anderson President and Chief Executive Officer | 425.0K | — | — | 1.19M | 127.5K | — | 1.75M | 68.35% | ↗ |
| 62 | 2014 | Bonnie H. Anderson President and Chief Executive Officer | 425.0K | — | — | 1.19M | 127.5K | — | 1.75M | 68.35% | ↗ |
| 63 | 2014 | Christopher M. Hall Chief Operating Officer | 341.2K | — | — | 819.5K | 61.4K | — | 1.22M | 67.06% | ↗ |
| 64 | 2014 | Christopher M. Hall Chief Operating Officer | 341.2K | — | — | 819.5K | 61.4K | — | 1.22M | 67.06% | ↗ |
| 65 | 2014 | Shelly D. Guyer Chief Financial Officer | 300.0K | — | — | 596.5K | 54.0K | — | 950.5K | 62.76% | ↗ |
| 66 | 2014 | Shelly D. Guyer Chief Financial Officer | 300.0K | — | — | 596.5K | 54.0K | — | 950.5K | 62.76% | ↗ |
| 67 | 2013 | Shelly D. Guyer Chief Financial Officer | 201.0K | — | — | 755.2K | 69.0K | — | 1.03M | 73.66% | ↗ |
| 68 | 2013 | Shelly D. Guyer Chief Financial Officer | 201.0K | — | — | 755.2K | 69.0K | — | 1.03M | 73.66% | ↗ |
| 69 | 2013 | Bonnie H. Anderson President and Chief Executive Officer | 380.0K | — | — | 305.9K | 170.0K | — | 855.9K | 35.74% | ↗ |
| 70 | 2013 | Christopher M. Hall Chief Commercial Officer Mark E. Spring | 316.3K | — | — | 76.0K | 80.0K | — | 472.3K | 16.09% | ↗ |
| 71 | 2013 | Christopher M. Hall Chief Operating Officer | 316.3K | — | — | 76.0K | 80.0K | — | 472.3K | 16.09% | ↗ |
| 72 | 2012 | Bonnie H. Anderson President and Chief Executive Officer | 355.0K | — | — | 302.6K | 62.5K | — | 720.1K | 42.02% | ↗ |
| 73 | 2012 | Christopher M. Hall Chief Commercial Officer Mark E. Spring | 304.1K | — | — | 93.1K | 30.5K | — | 427.7K | 21.76% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Marc A. Stapley | Chief Executive Officer & Director | 2M | male |
| Phillip G. Febbo | Chief Scientific & Medical Officer | 930.1K | — |
| Rebecca Chambers | Executive Vice President & Chief Financial Officer | 912.0K | female |
| John Leite | Global Chief Commercial Officer | 846.5K | — |
| Annie McGuire | Executive VP, General Counsel & Head of Market Access | 829.5K | female |
| Kevin Richard Haas | Chief Development and Technology Officer | — | — |
| Steven French | Senior Vice President & Chief Information Officer | — | male |
| Corinne Danan | Senior Vice President | — | female |
| Jonathan Wygant | Vice President & Chief Accounting Officer | — | male |
| Karen Possemato | Senior Vice President of Corporate Marketing, Communications & Commercial Operations | — | female |
| Keith Gligorich | Senior Vice President of Global Operations | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-03-10 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-11-12 | 2025-12-15 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-06-16 | 2025-07-11 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-10-16 | 2023-11-11 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2023-09-15 | 2023-10-15 | Josh Gottheimer | NJ05 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2023-04-10 | 2023-05-19 | Daniel Goldman | NY10 | — | Sale | $1,001 - $15,000 | ↗ |
| 2020-12-23 | 2021-01-11 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-12-10 | 2021-01-11 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-12-08 | 2021-01-07 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-10-29 | 2020-11-05 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-01-17 | 2020-02-18 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2019-12-24 | 2020-01-10 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2019-12-12 | 2020-01-10 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2019-12-06 | 2020-01-06 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VCYT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
